Nippon India Pharma Fund - Direct Plan Growth Plan - Bonus Option
(Erstwhile Reliance Pharma Fund - Direct Plan Growth Plan - Bonus Option)
Fund House: Nippon India Mutual Fund| Category: Equity: Sectoral-Pharma and Healthcare |
| Launch Date: 01-01-2013 |
| Asset Class: Equity |
| Benchmark: BSE Healthcare TRI |
| TER: 0.92% As on (31-05-2024) |
| Status: Open Ended Schemes |
| Minimum Investment: 5000.0 |
| Minimum Topup: 0.0 |
| Total Assets: 8,080.19 Cr As on 31-03-2025(Source:AMFI) |
| Turn over: 12% | Exit Load: Exit load of 1% if redeemed within 1 month. |
552.45
0.43 (0.0781%)
18.2%
Benchmark: 14.99%
PERFORMANCE
Returns Type:
of :
Start :
End :
Period:
This Scheme
-
vs
NIFTY Healthcare TRI
-
Gold
-
PPF
-
Returns Type:
of :
Period:
Start :
Period:
Fund Multiplier
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
Time Taken To Multiply
2x
4x
5x
10x
FUND
0 Years 0 Months
0 Years 0 Months
0 Years 0 Months
1 Years 6 Months
FD
11 years 10 Months
GOLD
8 years 9 Months
NIFTY
5 years 5 Months
Investment Objective
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
Current Asset Allocation (%)
Indicators
| Standard Deviation | 15.88 |
| Sharpe Ratio | 0.75 |
| Alpha | 2.71 |
| Beta | 0.87 |
| Yield to Maturity | - |
| Average Maturity | - |
PEER COMPARISON
Scheme Characteristics
Minimum investment in equity & equity related instruments of a particular sector/ particular theme - 80% of total assets.
Riskometer
PORTFOLIO
Market Cap Distribution
Small Cap
28.16%
Others
0.52%
Large Cap
37.81%
Mid Cap
33.51%
